Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in Centessa Pharmaceuticals plc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
44
−3 vs. Q4 2021
Shares held
74.6M
+2.71M (+3.8%) vs. Q4 2021
Total value
$669.1M
−$138.7M (−17.2%) vs. Q4 2021
New holders
5
16 more added
Sold out
8
13 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 44 institutions
Q1 2021: 0 institutionsQ2 2021: 50 institutionsQ3 2021: 40 institutionsQ4 2021: 47 institutionsQ1 2022: 44 institutionsQ2 2022: 41 institutionsQ3 2022: 44 institutionsQ4 2022: 44 institutionsQ1 2023: 44 institutionsQ2 2023: 45 institutionsQ3 2023: 49 institutionsQ4 2023: 58 institutionsQ1 2024: 69 institutionsQ2 2024: 80 institutionsQ3 2024: 103 institutionsQ4 2024: 114 institutionsQ1 2025: 130 institutionsQ2 2025: 117 institutionsQ3 2025: 125 institutionsQ4 2025: 147 institutionsQ1 2026: 161 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $669.1M
Q1 2021: $0Q2 2021: $1.05BQ3 2021: $947.5MQ4 2021: $807.8MQ1 2022: $669.1MQ2 2022: $350.3MQ3 2022: $288.7MQ4 2022: $194.4MQ1 2023: $257.5MQ2 2023: $435.4MQ3 2023: $469.6MQ4 2023: $567.4MQ1 2024: $840.7MQ2 2024: $781.2MQ3 2024: $1.74BQ4 2024: $2.08BQ1 2025: $1.80BQ2 2025: $1.62BQ3 2025: $3.11BQ4 2025: $3.60BQ1 2026: $5.90BQ2 2026: $0
Institutions holding CNTA and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 2026161$5.90B
Q4 2025147$3.60B
Q3 2025125$3.11B
Q2 2025117$1.62B
Q1 2025130$1.80B
Q4 2024114$2.08B
Q3 2024103$1.74B
Q2 202480$781.2M
Q1 202469$840.7M
Q4 202358$567.4M
Q3 202349$469.6M
Q2 202345$435.4M
Q1 202344$257.5M
Q4 202244$194.4M
Q3 202244$288.7M
Q2 202241$350.3M
Q1 202244$669.1M
Q4 202147$807.8M
Q3 202140$947.5M
Q2 202150$1.05B
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q4 2021.

Institutions holding CNTA in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Medicxi Ventures Management (Jersey) Ltd19,963,157$179.1M48.51%+1,839,265+10.1%Added
Index Venture Life Associates VI Ltd9,961,789$89.4M100.00%00.0%Unchanged
General Atlantic LLC9,681,818$86.8M0.79%00.0%Unchanged
Janus Henderson Group PLC5,617,819$50.4M0.02%−125,578−2.2%Reduced
Vida Ventures Advisors, LLC3,931,818$35.3M20.51%00.0%Unchanged
Ra Capital Management, L.P.3,577,094$32.1M0.70%00.0%Unchanged
OUP Management Co., LLC2,937,615$26.4M20.06%+595,724+25.4%Added
Price T Rowe Associates Inc2,528,583$22.7M0.00%+451,813+21.8%Added
Cormorant Asset Management, LP2,489,894$22.3M1.71%00.0%Unchanged
Samsara BioCapital, LLC1,884,096$16.9M4.27%+424,403+29.1%Added
BVF Inc1,755,545$15.7M0.63%+1,301,000+286.2%Added
Boxer Capital, LLC1,251,137$11.3M0.58%00.0%Unchanged
Baker Bros. Advisors LP1,127,273$10.1M0.06%00.0%Unchanged
Driehaus Capital Management LLC1,053,142$9.45M0.12%−32,555−3.0%Reduced
Point72 Asset Management, L.P.907,000$8.14M0.04%−190,908−17.4%Reduced
Woodline Partners LP882,633$7.92M0.13%+81,497+10.2%Added
Wellington Management Group LLP727,273$6.52M0.00%00.0%Unchanged
Kynam Capital Management, LP669,100$6.00M1.95%+430,059+179.9%Added
Franklin Resources Inc616,903$5.53M0.00%+41,365+7.2%Added
American Century Companies Inc517,235$4.64M0.00%+1120.0%Added
EcoR1 Capital, LLC454,545$4.08M0.13%−427,631−48.5%Reduced
Logos Global Management LP454,545$4.08M0.53%00.0%Unchanged
VR Adviser, LLC411,361$3.69M0.60%−715,911−63.5%Reduced
Ensign Peak Advisors, Inc316,601$2.84M0.01%−26,691−7.8%Reduced
Citadel Advisors LLC304,426$2.73M0.00%−35,639−10.5%Reduced
BlackRock Inc.276,518$2.48M0.00%−10,720−3.7%Reduced
Affinity Asset Advisors, LLC65,282$586.0K0.23%−353,862−84.4%Reduced
Manufacturers Life Insurance Company, The57,421$518.5K0.00%+57,421New
Bank of America Corp44,177$396.0K0.00%−35,068−44.3%Reduced
TD Asset Management Inc33,252$298.0K0.00%00.0%Unchanged
Morgan Stanley21,612$194.0K0.00%+7,527+53.4%Added
Golden State Equity Partners15,970$143.0K0.07%+2,100+15.1%Added
Virtus ETF Advisers LLC13,969$125.0K0.06%−829−5.6%Reduced
Prelude Capital Management, LLC11,400$102.0K0.00%+11,400New
FMR LLC10,300$92.0K0.00%−84,000−89.1%Reduced
JPMorgan Chase & Co4,716$42.0K0.00%+207+4.6%Added
Tower Research Capital LLC (TRC)1,245$11.0K0.00%+315+33.9%Added
Advisor Group Holdings, Inc.1,015$9.00K0.00%+265+35.3%Added
Citigroup Inc911$8.00K0.00%−118−11.5%Reduced
Adirondack Trust Co925$8.00K0.00%+525+131.3%Added
Global Retirement Partners, LLC350$2.00K0.00%+350New
State of Wyoming73$1.00K0.00%+12+19.7%Added
Kayne Anderson Rudnick Investment Management LLC80$1.00K0.00%+80New
Point72 Hong Kong Ltd8$00.00%+8New
Deep Track Capital, LP0$00.00%−400,000−100.0%Sold out
Verition Fund Management LLC0$00.00%−50,000−100.0%Sold out
Nan Fung Group Holdings Ltd0$00.00%−22,200−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−10,426−100.0%Sold out
Northern Trust Corp0$00.00%−8,884−100.0%Sold out
Compagnie Lombard Odier SCmA0$00.00%−5,820−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−632−100.0%Sold out
UBS Group AG0$00.00%−496−100.0%Sold out